109 related articles for article (PubMed ID: 8647661)
21. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
[TBL] [Abstract][Full Text] [Related]
22. CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease.
Sallakci N; Bacanli A; Coskun M; Yavuzer U; Alpsoy E; Yegin O
Clin Exp Dermatol; 2005 Sep; 30(5):546-50. PubMed ID: 16045690
[TBL] [Abstract][Full Text] [Related]
23. The functional role of nuclear factor kappa-kappaB1 -94 ins/del ATTG promotor gene polymorphism in Behçet's disease: an exploratory study.
Yalcin B; Atakan N; Alli N
Clin Exp Dermatol; 2008 Aug; 33(5):629-33. PubMed ID: 18616724
[TBL] [Abstract][Full Text] [Related]
24. Paediatric Behçet's disease in Iran: report of 204 cases.
Shahram F; Nadji A; Akhlaghi M; Faezi ST; Chams-Davatchi C; Shams H; Ghodsi SZ; Davatchi F
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):135-140. PubMed ID: 29998839
[TBL] [Abstract][Full Text] [Related]
25. Circulating soluble CD28 in patients with Behçet's disease: relationship to clinical manifestations.
Hamzaoui K; Hamzaoui A; Bouajina L; Houman H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S49-52. PubMed ID: 16273764
[TBL] [Abstract][Full Text] [Related]
26. Clinical features of Behçet's disease in children.
Borlu M; Ukşal U; Ferahbaş A; Evereklioglu C
Int J Dermatol; 2006 Jun; 45(6):713-6. PubMed ID: 16796634
[TBL] [Abstract][Full Text] [Related]
27. Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation.
Cuchacovich M; Merino G; Yamamoto JH; Villarroel F; Saavedra T; Jofre S; Gatica H; Velasquez V; Pizzo SV; Gonzalez-Gronow M
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S27-34. PubMed ID: 16273761
[TBL] [Abstract][Full Text] [Related]
28. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
29. Circulating NK cells and their subsets in Behçet's disease.
Hasan MS; Ryan PL; Bergmeier LA; Fortune F
Clin Exp Immunol; 2017 May; 188(2):311-322. PubMed ID: 28170096
[TBL] [Abstract][Full Text] [Related]
30. The proportional Venn diagram of Behçet's disease-related manifestations among young adult men in Turkey.
Dinc A; Bayir A; Simsek I; Erdem H; Pay S; Turan M
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S86-90. PubMed ID: 16273772
[TBL] [Abstract][Full Text] [Related]
31. Bcl-2 expression in skin pathergy reaction of Behçet's disease.
Sullu Y; Senturk N; Yildiz L; Sullu YD; Turanli AY
Dermatology; 2001; 202(2):90-3. PubMed ID: 11306827
[TBL] [Abstract][Full Text] [Related]
32. Predictive Factors of Severe Behçet's disease: A Longitudinal, Prospective Cohort Followed Between 1981-2020.
Serpa Pinto L; Xavier Pires S; Silva B; Farinha F; Vasconcelos C; Araújo Correia J
Reumatol Clin (Engl Ed); 2021 May; ():. PubMed ID: 34023233
[TBL] [Abstract][Full Text] [Related]
33. Immunopathogenic characterization of cutaneous inflammation in Behçet's disease.
Cho S; Kim J; Cho SB; Zheng Z; Choi MJ; Kim DY; Bang D
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):51-7. PubMed ID: 23216454
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous vasculitis in Behçet's disease: a clinical and histopathologic study of 20 patients.
Chen KR; Kawahara Y; Miyakawa S; Nishikawa T
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):689-96. PubMed ID: 9146529
[TBL] [Abstract][Full Text] [Related]
35. Influence of sex on patients with Behçet's disease in Korea.
Bang DS; Oh SH; Lee KH; Lee ES; Lee SN
J Korean Med Sci; 2003 Apr; 18(2):231-5. PubMed ID: 12692421
[TBL] [Abstract][Full Text] [Related]
36. Clinical features of Behcet's disease in patients without oral aphthosis.
Faezi ST; Paragomi P; Shahram F; Shams H; Shams-Davatchi C; Ghodsi Z; Nadji A; Akhlaghi M; Davatchi F
Mod Rheumatol; 2014 Jul; 24(4):637-9. PubMed ID: 24252007
[TBL] [Abstract][Full Text] [Related]
37. Case of Behçet's disease complicated by oculomotor nerve palsy associated with internal carotid artery-posterior communicating artery aneurysm.
Yamaoka T; Murota H; Katayama I
J Dermatol; 2015 Mar; 42(3):315-7. PubMed ID: 25573207
[TBL] [Abstract][Full Text] [Related]
38. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.
Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507
[TBL] [Abstract][Full Text] [Related]
39. How to deal with Behcet's disease in daily practice.
Davatchi F; Shahram F; Chams-Davatchi C; Shams H; Nadji A; Akhlaghi M; Faezi T; Sadeghi Abdollahi B
Int J Rheum Dis; 2010 May; 13(2):105-16. PubMed ID: 20536594
[TBL] [Abstract][Full Text] [Related]
40. Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients.
Houman MH; Neffati H; Braham A; Harzallah O; Khanfir M; Miled M; Hamzaoui K
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S58-64. PubMed ID: 17949553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
